UC. Effects of KCNE2 on HCN isoforms: distinct modulation of membrane expression and single channel properties. Am J Physiol Heart Circ Physiol 297: H355-H363, 2009. First published May 8, 2009 doi:10.1152/ajpheart.00154.2009.-Hyperpolarization-activated cation (HCN) channels give rise to an inward current with similar but not identical characteristics compared with the pacemaker current (I f), suggesting that HCN channel function is modulated by regulatory ␤-subunits in native tissue. KCNE2 has been proposed to serve as a ␤-subunit of HCN channels; however, available data remain contradictory. To further clarify this situation, we therefore analyzed the effect of KCNE2 on whole cell currents, single channel properties, and membrane protein expression of all cardiac HCN isoforms in the CHO cell system. On the whole cell level, current densities of all HCN isoforms were significantly increased by KCNE2 without altering voltage dependence or current reversal. While these results correlated well with the KCNE2-mediated 2.2-fold and 1.6-fold increases of membrane protein levels of HCN2 and HCN4, respectively, no effect of KCNE2 on HCN1 expression was obtained. All HCN subtypes displayed faster activation kinetics upon coexpression with KCNE2. Most importantly, for the first time, we demonstrated modulation of single channel function by KCNE2, thus supporting direct functional interaction with HCN subunits. In the presence of KCNE2, the single channel amplitudes and conductance of HCN1, HCN2, and HCN4 were significantly increased versus control recordings. Mean open time was significantly increased in cells coexpressing HCN2 ϩ KCNE2, whereas it was unaffected in HCN1 ϩ KCNE2 cotransfected cells and reduced in HCN4 ϩ KCNE2 cotransfected cells compared with the respective HCN subunits alone. Thus, we demonstrate KCNE2-mediated distinct effects on HCN membrane expression and direct functional modulation of HCN isoforms, further supporting that KCNE2 surves as a regulatory ␤-subunit of HCN channels. pacemaker current; hyperpolarization-activated cation; MinK-related peptide; electrophysiology THE HYPERPOLARIZATION-ACTIVATED CATION (HCN) channel current (I f ; also known as I h ) has been identified in various regions of the mammalian heart, brain, peripheral nervous system, and eye (3). In the sinus node, Purkinje cells, and neonatal cardiomyocytes, I f is considered to contribute significantly to spontaneous pacemaker activity (7, 8, 28 ). An I f -like current has also been recorded in ventricular and atrial myocytes of mammalian species and in human myocardial tissue (10, 11, 31) .
cies, cardiac regions, and developmental stages (24, 27) . In heterologous expression, all HCN channels give rise to a hyperpolarization-activated inward current with similar but not identical characteristics compared with native I f (9, 16, 26) . These observations suggest that HCN channel function is likely to be modulated by regulatory ␤-subunits in neural and myocardial tissue.
MinK-related peptide 1, encoded by KCNE2, is a member of a family of single transmembrane-spanning proteins (1) . Expression of KCNE2 has been detected in the rat brain and in various regions of the heart, with the highest expression levels in the sinus node and Purkinje fibers (1, 14, 22, 30, 32) . KCNE2 has been found to modulate several voltage-gated K ϩ channel ␣-subunits, including the delayed rectifier K ϩ current subunits HERG, KCNQ1, and KCNQ2 (1, 29, 30) and the transient outward K ϩ current subunits Kv4.2 and Kv4.3 (6, 33) . Moreover, it has been proposed that KCNE2 might serve as a ␤-subunit of HCN channels; however, as available data remain contradictory, some researchers have questioned the regulatory properties of KCNE2 for these channels (2, 4, 23, 25, 32) . Given the wide and colocalized expression of both subunits in the brain and heart, further insight in the modulating impact of KCNE2 on HCN isoforms might prove helpful for the understanding and therapeutic manipulation of rhythmic activity. Therefore, in the present work, we used heterologous expression of KCNE2 and all cardiac HCN isoforms in the CHO cell system to investigate the effect of KCNE2 on HCN whole cell currents and HCN membrane protein expression. Most importantly, we analyzed the impact of KCNE2 on HCN single channel properties to possibly obtain direct evidence for a functional interaction of both subunits in channel complexes. Our results demonstrate distinct modulation of the different HCN subtypes by KCNE2.
METHODS

Plasmid Construction
The expression plasmids pAdCGI-HCN1, pAdCGI-HCN2, and pAdCGI-HCN4 (encoding the full-length sequences of mouse HCN1, mouse HCN2, and human HCN4 genes, respectively) as well as pAdCGI and pAdCGI-KCNE1-D76N have been previously described (8, 12, 15, 21) . The coding sequence of red fluorescent protein (RFP; pDsRed, Clontech, Saint-Germain-en-Laye, France) was cloned into pAdCGI in place of the enhanced green fluorescent protein (EGFP) sequence to generate pAdCRI. The full-length coding sequence of human KCNE2 was PCR amplified from genomic DNA, control sequenced, and cloned into the multiple cloning site of pAdCRI to generate pAdCRI-KCNE2.
Transient Transfections
Twenty-four hours before transfection, CHO-K1 cells (CCL 61, American Type Culture Collection, Manassas, VA) were seeded at a density of 2.0 ϫ 10 5 cells/35-mm dish for electrophysiological experiments and 2.0 ϫ 10 6 cells/10-cm dish for Western blot analysis. For electrophysiology, cells were cotransfected with 0.5 g/well plasmid DNA of HCN channels (as indicated) and 0.5 g/well plasmid DNA of KCNE2 or an empty plasmid using Lipofectamine Plus (Life Technologies, Gaithersburg, MD) as directed by the manufacturer. After 4 h, transfection media were replaced with normal growth media. For Western blot analysis, cells were cotransfected with 3.0 g/well plasmid DNA of HCN channels and 3.0 g/well plasmid DNA of KCNE2 using Fugene 6 (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's protocol.
Electrophysiology
Patch-clamp recordings in the whole cell configuration. Experiments were carried out using standard microelectrode whole cell patch-clamp techniques at room temperature (21-23°C). Currents were recorded and digitized with an Axopatch 200B amplifier and Digidata 1200 interface (Axon Instruments, Foster City, CA) while being sampled at 10 kHz and filtered at 2 kHz (8, 11) . The recording bath solution containing (in mmol/l) 100 KCl, 40 NaCl, 2 CaCl 2, 1 MgCl 2, 10 glucose, and 10 HEPES; pH was adjusted to 7.4 with NaOH. The pipette solution contained (in mmol/l) 135 K-glutamate, 5 NaCl, 1 MgCl 2, 10 HEPES, and 5 Mg-ATP; pH was adjusted to 7.3 Fig. 1 . Effect of KCNE2 on hyperpolarization-actived cation channel (HCN)1 whole cell current. A: representative HCN1 whole cell current recordings in the absence and presence of KCNE2. From a holding potential of Ϫ35 mV, cells were hyperpolarized in a 10-mV decrement family to Ϫ150 mV followed by a depolarization step to 20 mV. Mean HCN1 current density, measured as the difference between the instantaneous current and steady-state current at the end of the hyperpolarization (B) or obtained from tail currents (D), was significantly increased by KCNE2. The voltage dependence of HCN1 calculated by Boltzmann fits of normalized conductances (g/gmax; C) and current reversal (E) showed no alteration by KCNE2. For data, see Table 1 . with KOH. Borosilicate microelectrodes had tip resistances of 2-4 M⍀ when filled with the internal recording solution.
HCN current size was measured as the difference between the instantaneous current at the beginning of a hyperpolarizing step (in mV, as indicated) and the steady-state current at the end of hyperpolarization, as previously described (8, 11) . In addition, tail current amplitudes were measured as the difference between peak current (I peak) and maintained current at the end of the clamp pulse and used to evaluate current reversal. For the calculation of activation curves, the specific current conductances (g) were normalized to the maximal current conductance (g max) to determine g/gmax. Boltzmann distributions were fitted to these normalized values as follows: g/gmax ϭ 1/{1 ϩ exp[(V1/2 Ϫ Vm)/S]}, where V1/2 is the voltage at half-maximal activation, Vm is the membrane voltage, and S is a slope factor at V m ϭ V1/2. Data were not corrected for the liquid junction potential of 11.3 mV. A xenon arc lamp was used to view EGFP at 488-nm excitation/530-nm emission and RFP at 557-nm excitation/579-nm emission.
Patch-clamp recordings of single channels in the cell-attached configuration. Single channel measurements and analysis were performed as previously described (18, 20, 21) . The external solution for single channel experiments contained (in mmol/l) 130 KCl, 10 NaCl, 5 EGTA, and 10 HEPES-KOH (pH 7.4 with KOH). This high-K ϩ solution was used to achieve a resting membrane potential of zero (13, 20, 21) . Borosilicate pipettes (7-10 M⍀) were filled with the following solution (in mmol/l): 70 KCl, 70 NaCl, 1 MgCl 2, and 5 HEPES-KOH (pH 7.4 with KOH). In some experiments, ivabradine (10 M, kindly provided by the Institut de Recherches Servier, Suresnes, Fig. 2 . Effect of KCNE2 on HCN2 whole cell current. A: representative HCN2 whole cell current recordings in the absence and presence of KCNE2. From a holding potential of Ϫ35 mV, cells were hyperpolarized in a 10-mV decrement family to Ϫ150 mV followed by a depolarization step to 20 mV. Mean HCN2 current density, measured as the difference between the instantaneous current and steadystate current at the end of hyperpolarization (B) or obtained from tail currents (D), was significantly increased by KCNE2. The voltage dependence of HCN2 calculated by Boltzmann fits of g/gmax (C) and current reversal (E) showed no alteration by KCNE2. For data, see Table 1 F: values of current activation plotted as a function of test potentials. KCNE2 accelerated the activation kinetics of HCN2 at physiological potentials. *P Ͻ 0.05 vs. control.
France) was added to the bath solution, as indicated. An Axopatch 200B amplifier, Digidata 1200 interface (Axon Instruments), and custom software were used for pulse generation, data acquisition (10 kHz), and filtering (2 kHz, Ϫ3 dB, 4-pole Bessel filter). All experiments were performed at room temperature (21-23°C). Single channels were hyperpolarized to Ϫ90 mV for a total duration of 3 s from a holding potential of Ϫ35 mV. Data were not corrected for the liquid junction potential of Ϫ2.1 mV. A xenon arc lamp was used to view EGFP at 488-nm excitation/530-nm emission and RFP at 557-nm excitation/579-nm emission.
Data analysis. Linear leak and capacity currents were digitally subtracted using the average currents of nonactive sweeps. Openings and closures were identified by the half-height criterion. The open probability (P o; defined as the relative occupancy of the open state during active sweeps), the availability (fraction of sweeps containing at least one channel opening), and the peak ensemble average current (I peak; obtained visually) were calculated from single channel and multichannel patches. In the latter case, they were corrected for the number of channels in the patch (n). n was defined as the maximum current amplitude observed divided by the unitary current. Single channel amplitudes were determined by direct measurements of fully resolved openings. I peak was corrected by division through n. The availability was corrected by the square root method as follows: (1 Ϫ corrected availability) is the nth root of (1 Ϫ uncorrected availability). The corrected P o was calculated on the basis of the corrected number of active sweeps, i.e., total open time/(n ϫ corrected availability ϫ Fig. 3 . Effect of KCNE2 on HCN4 whole cell current. A: representative HCN4 whole cell current recordings in the absence and presence of KCNE2. From a holding potential of Ϫ35 mV, cells were hyperpolarized in a 10-mV decrement family to Ϫ180 mV followed by a depolarization step to 20 mV. Mean HCN4 current density, measured as the difference between the instantaneous current and steadystate current at the end of hyperpolarization (B) or obtained from tail currents (D), was significantly increased by KCNE2. The voltage dependence of HCN4 calculated by Boltzmann fits of g/gmax (C) and current reversal (E) showed no alteration by KCNE2. For data, see Table 1 . F: values of current activation plotted as a function of test potentials. KCNE2 accelerated the activation kinetics of HCN4 at potentials of less than or equal to Ϫ120 mV. *P Ͻ 0.05 vs. control. number of test pulses ϫ pulse length). Closed time and first latency analyses were carried out only in one-channel patches.
Preparation of Membrane Protein and Western Blot Analysis
Transfected CHO cells were collected from petri dishes and resuspended in PBS containing a protease inhibitor mix (Roche Diagnostics, Mannheim, Germany). Preparation of the membrane protein fraction was performed as previously described (19) . The suspension was subjected to three subsequent freeze-thaw steps on dry icemethanol at 37°C and afterward sheared by being passing 20 times through a 20-gauge needle. After centrifugation at 300 g, the supernatant was centrifuged at 16,000 g to sediment the membrane fraction. The obtained pellet was lysed in buffer containing 1 mmol/l PMSF, 10 mmol/l Tris ⅐ HCl (pH 7.5), 10 mmol/l EDTA, 50 mmol/l NaCl, 50 mmol/l NaF, 20 g/ml aprotinin, 0.1% (vol/vol) Triton X-100, and 0.1% (vol/vol) ␤-mercaptoethanol. The protein concentration was assayed using a commercial protein assay (BCA method, Pierce). After standard Laemmli SDS-PAGE (7.5%) and Western blot analysis (BioRad Tankblot system, nitrocellulose membrane) had been performed, proteins were detected using rabbit anti-HCN1 (1:1,000), anti-HCN2 (1:500), or anti-HCN4 (1:1,000) antibodies (Alomone Labs, Jerusalem, Israel) as the first antibody and horseradish peroxidase-coupled antirabbit secondary antibody (1:2,000, Sigma-Aldrich, St. Louis, MO). Immunoreactive bands were stained with ECL reagents (Amersham Pharmacia Biotech) according to the manufacturer's instructions. Use of primary antibody to ␤-actin served as a loading control (Sigma-Aldrich). Densitometrical analysis of protein induction was performed using a charge-coupled device camera DIANA III (Raytest, Straubenhardt, Germany) with AIDA densitometry analysis software (Raytest).
Statistical Analysis
Pooled data are presented as means Ϯ SE. Comparisons between groups were performed with one-way ANOVA. Significant ANOVAs were followed by post hoc tests applying the Bonferroni correction for multiple comparisons. P values of Ͻ0.05 were deemed significant.
RESULTS
Effects of KCNE2 on Whole Cell Current of HCN Isoforms
To evaluate the effect of KCNE2 on HCN whole cell currents, CHO cells were transiently transfected with different HCN isoforms in the presence of wild-type KCNE2 or an empty plasmid (to exclude nonspecific effects; control). The combination of cytosolic green and red fluorescence verified effective cotransfection with both the plasmid encoding the HCN subunit and the KCNE2 construct, respectively.
Original current recordings and mean data demonstrated that KCNE2 significantly increased whole cell current densities of all HCN isoforms. HCN1 current density was substantially larger in the presence of KCNE2 at potentials negative to Ϫ110 Fig. 5 . Effect of KCNE2 on single channel conductance and HCN channel inhibition by ivabradine (Iva). A, C, and E: single channel amplitude of HCN channels with (F) and without (E) KCNE2 as a function of test potential. Slope conductances were calculated based on individual data (n Ն 5). See Table 2 for average values determined by linear regression. B, D, and F: Iva (10 M) blocked HCN single channel current during repetitive activation/deactivation steps (Ϫ90 mV, 150 ms/ϩ10 mV, 600 ms). Open probability decreased after Iva (10 M) application. mV [HCN1: 45.6 Ϯ 5.7 pA/pF (n ϭ 22) vs. HCN1 ϩ KCNE2: 68.7 Ϯ 8.8 pA/pF (n ϭ 17) at Ϫ120 mV, P Ͻ 0.05; Fig. 1, A  and B] . Consistently, HCN2 ϩ KCNE2 and HCN4 ϩ KCNE2 whole cell current sizes were significantly larger than HCN2 [HCN2: 41.8 Ϯ 9.3 pA/pF (n ϭ 17) vs. HCN2 ϩ KCNE2: 86.6 Ϯ 12.2 pA/pF (n ϭ 15) at Ϫ120 mV, P Ͻ 0.05; Fig. 2, A and B] and HCN4 [HCN4: 10.4 Ϯ 1.3 pA/pF (n ϭ 13) vs. HCN4 ϩ KCNE2: 23.5 Ϯ 5.0 pA/pF (n ϭ 10) at Ϫ140 mV, P Ͻ 0.05; Fig. 3, A and B] , respectively, at voltages negative to Ϫ90 mV. These results, which were obtained by measuring current amplitude as the difference between the instantaneous current and steady-state current at the end of hyperpolarization, were further supported by the analysis of the respective tail currents (Figs. 1D, 2D and 3D and Table 1 ). This increase of current size was not caused by a simple shift of HCN voltage dependence, since half-maximal activation potentials and slope factors of HCN1, HCN2, and HCN4 were not affected by KCNE2 (Figs. 1C, 2C , and 3C and Table 1 ). KCNE2 did not alter the reversal potential of any of the three HCN isoforms (Figs. 1E, 2E , and 3E and Table 1) .
Moreover, KCNE2 significantly modified the activation kinetics of HCN channels, suggesting a functional interaction with ␣-subunits. KCNE2 accelerated the current activation of isoforms HCN1 and HCN2 at physiological voltages from Ϫ70 to Ϫ90 mV (Figs. 1F and 2F and Table 1 ). Given the very slow activation of HCN4, no reliable activation time constants may be calculated at test potentials positive to Ϫ120 mV (4). However, we obtained significantly smaller time contant values for HCN4 in the presence of KCNE2 at all voltages from Ϫ120 to Ϫ150 mV ( Fig. 3F and Table 1 ).
KCNE2 Causes Differential Changes of HCN1, HCN2, and HCN4 Single Channel Properties
While changes of current kinetics in whole cell recordings indirectly indicate the functional interaction of HCN channel subunits by KCNE2, currently no direct evidence demonstrating the modulation of single channel properties is available. Therefore, we performed patch-clamp recordings of single HCN1, HCN2, and HCN4 channels expressed in CHO cells with or without the addition of KCNE2. Previously, we (18, 20) have confirmed HCN single channel identity in our experimental setting by demonstrating cAMP sensitivity and block by the specific inhibitor ivabradine.
Transfected cells were continuously hyperpolarized to Ϫ90 mV for 3 s from a holding potential of Ϫ35 mV (18, 20, 21) . Indeed, KCNE2 modified the single channel properties of all HCN isoforms. KCNE2 increased single channel amplitude and conductance (Figs. 4 and 5 , A, C, and E, and Table 2 ). Consistent with our whole cell recordings showing an acceleration of channel activation in the presence of KCNE2, KCNE2 reduced the single channel first latency of all HCN subunits (Table 2) . Effects on other gating parameters were distinct between the HCN isoforms. KCNE2 significantly reduced the availability of HCN1 (Fig. 4, A and B, and Table  2 ). Moreover, KCNE2 increased P o , prolonged the mean open time, and decreased the mean closed time of HCN2. In contrast, the mean open time of HCN4 was shortened by KCNE2 ( Fig. 4C and Table 2 ), whereas the mean closed time of HCN4 remained unaltered. HCN single channel identity was confirmed by the addition of ivabradine (Fig. 5,  B, D, and F) .
Effect of KCNE2 on HCN Protein Expression
While KCNE2 effects on single channel parameters well supported the direct functional interaction with HCN subunits, changes of whole cell current size could additionally be based on altered HCN expression levels. Thus, to further clarify this situation, we evaluated the action of KCNE2 on membrane protein expression of HCN1, HCN2, and HCN4 using Western blot analysis. Figure 6A shows typical antibody stains against the different HCN isoforms in the absence and presence of KCNE2. Whereas HCN1 expression was unaffected by KCNE2 compared with controls, KCNE2 cotransfection led to significantly increased membrane protein levels of HCN2 and HCN4. Semiquantitative analysis demonstrated an increase of HCN2 and HCN4 to 220.5 Ϯ 40.1% (n ϭ 4) and 164.7 Ϯ 11.0% (n ϭ 5), respectively, compared with control channel protein expression levels (Fig. 6B) .
DISCUSSION
Our experiments demonstrate distinct effects of KCNE2 on HCN isoforms. At the whole cell level, current densities of all HCN isoforms were significantly increased by KCNE2 without altering voltage dependence or current reversal. While these results correlated well with KCNE2-mediated 2.2-fold and 1.6-fold increases of membrane protein levels of HCN2 and HCN4, respectively, no effect of KCNE2 on HCN1 expression was obtained. All HCN subtypes displayed faster activation kinetics upon coexpression with KCNE2. Most importantly, for the first time, we demonstrate modulation of single channel properties by KCNE2, supporting a direct functional interaction with HCN channels.
The ability to generate slow, spontaneous diastolic depolarizations via I f is the molecular basis of automaticity in specific regions of the heart and nervous system. HCN channels have been identified to underlie native I f . However, heterologously expressed HCN channels insufficiently match the electrophysiological and pharmacological properties of native I f . Experimental evidence has indicated that heteromultimerization of different HCN isoforms and/or the presence of regulatory subunits contribute to the specific properties of the native channel. KCNE2 was suggested to serve as a ␤-subunit of HCN channels. Consistent with our whole cell recordings, previously KCNE2 has been shown to significantly increase the current density of HCN2 current in Xenopus oocytes and neonatal cardiomyocytes (25, 32) and enhance HCN4 current size in CHO cells and oocytes (4). However, some authors (2) have questioned the regulatory function of KCNE2 for HCN channels as they did not obtain any effect of KCNE2 on HCN4 or heteromeric HCN4-1 tandem channels in HEK-293 cells, most likely due to different experimental conditions.
To further clarify this situation and assess possible direct regulatory effects of KCNE2 on HCN channel properties, we therefore performed single channel recordings of all cardiac HCN isoforms in the presence and absence of KCNE2. We confirmed the modulation of single channel parameters of all subunits by KCNE2, supporting the notion that KCNE2 may function as a ␤-subunit in HCN channel complexes. For all HCN isoforms, a significant increase in single channel amplitude and single channel conductance was detected in the presence of KCNE2. While these results are consistent with our whole cell data and could also explain the obtained whole cell current increase of HCN1 despite unchanged protein expression levels, it has to be noted that changes of single channel parameters may not just be summed up to quantify whole cell current modulation, as for HCN channels cooperative gating has been demonstrated in recordings of multichannel macropatches, underlying whole cell current activation kinetics and thus substantially contributing to whole cell current size (5, 20) . It remains to be undetermined how KCNE2 modulates these interactions between several HCN channel complexes. Notably, other gating parameters besides single channel amplitude were modulated in a variable subtypespecific fashion by KCNE2, suggesting different interaction modalities between the subunits.
The increase of whole cell HCN current density by KCNE2 might be due only to enhanced single channel activity or additional elevated expression levels of HCN channels, as previously indicated (32) . We extended these observations, demonstrating a substantial increase of HCN2 and HCN4 membrane protein levels upon coexpression with KCNE2, whereas HCN1 expression remained unaltered. These results suggest that KCNE2 might stabilize HCN2/HCN4 protein complexes or function as a chaperone of HCN channel trafficking. The precise mechanism is currently under investigation.
Thus, we showed distinct modulating effects of KCNE2 on single channel function and on membrane expression of different HCN isoforms, indicating that the regulatory properties of KCNE2 may further add to the diversity of native I f characteristics in vivo. 
